CoChat

Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial

Abreha, Tesfay, Hwang, Jimee, Thriemer, Kamala, Tadesse, Yehualashet, Girma, Samuel, Melaku, Zenebe, Assef, Ashenafi, Kassa, Moges, Chatfield, Mark D., Landman, Keren Z., Chenet, Stella M., Lucchi, Naomi W., Udhayakumar, Venkatachalam, Zhou, Zhiyong, Shi, Ya Ping, Kachur, S. Patrick, Jima, Daddi, Kebede, Amha, Solomon, Hiwot, Mekasha, Addis, Alemayehu, Bereket Hailegiorgis, Malone, Joseph L., Dissanayake, Gunewardena, Teka, Hiwot, Auburn, Sarah, von Seidlein, Lorenz, Price, Ric N. · 2017 · PLOS Medicine
Cited by 82

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002299

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

14 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 31

  1. CA Guerra, 2010, The international limits and population at risk of Plasmodium vivax transmission in 2009, PLoS Negl Trop Dis, 4, e774, 10.1371/journal.pntd.0000774 · DOI · Paper page
  2. RN Price, 2007, Vivax malaria: neglected and not benign, Am J Trop Med Hyg, 77, 79, 10.4269/ajtmh.2007.77.79 · DOI · Paper page
  3. RN Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, 14, 982, 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
  4. NM Douglas, 2014, Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia, BMC Med, 12, 217, 10.1186/s12916-014-0217-z · DOI
  5. RN Price, 2009, New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance, Curr Opin Infect Dis, 22, 430, 10.1097/QCO.0b013e32832f14c1 · DOI · Paper page
  6. W Nigatu, 1992, Plasmodium vivax and P. falciparum epidemiology in Gambella, south-west Ethiopia, Trop Med Parasitol, 43, 181
  7. D Olana, 2011, Malaria, Oromia regional state, Ethiopia, 2001–2006, Emerg Infect Dis, 17, 1336, 10.3201/eid1707.100942 · DOI
  8. J Manuel Ramos, 2005, Change in epidemiology of malaria infections in a rural area in Ethiopia, J Travel Med, 12, 155, 10.2310/7060.2005.12304 · DOI
  9. NW Lucchi, 2014, PET-PCR method for the molecular detection of malaria parasites in a national malaria surveillance study in Haiti, 2011, Malar J, 13, 462, 10.1186/1475-2875-13-462 · DOI
  10. M Imwong, 2007, Contrasting genetic structure in Plasmodium vivax populations from Asia and South America, Int J Parasitol, 37, 1013, 10.1016/j.ijpara.2007.02.010 · DOI · Paper page
  11. DA Joy, 2008, Local adaptation and vector-mediated population structure in Plasmodium vivax malaria, Mol Biol Evol, 25, 1245, 10.1093/molbev/msn073 · DOI · Paper page
  12. LC Patchen, 1983, Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection, J Chromatogr, 278, 81, 10.1016/S0378-4347(00)84758-1 · doi:10.1016/s0378-4347(00)84758-1
  13. S Pukrittayakamee, 2014, Pharmacokinetic interactions between primaquine and chloroquine, Antimicrob Agents Chemother, 58, 3354, 10.1128/AAC.02794-13 · doi:10.1128/aac.02794-13
  14. M Cabrera, 2015, In vitro activities of primaquine-schizonticide combinations on asexual blood stages and gametocytes of Plasmodium falciparum, Antimicrob Agents Chemother, 59, 7650, 10.1128/AAC.01948-15 · doi:10.1128/aac.01948-15
  15. RN Price, 2012, Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax, Trends Parasitol, 28, 522, 10.1016/j.pt.2012.08.005 · DOI
  16. SK Mekonnen, 2014, Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia, Malar J, 13, 244, 10.1186/1475-2875-13-244 · DOI · Paper page
  17. M Schunk, 2006, High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia, Malar J, 5, 54, 10.1186/1475-2875-5-54 · DOI
  18. S Getachew, 2015, Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia, Malar J, 14, 525, 10.1186/s12936-015-1041-4 · DOI · Paper page
  19. T Ketema, 2011, Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia, Parasit Vectors, 4, 46, 10.1186/1756-3305-4-46 · DOI · Paper page
  20. JK Baird, 2004, Chloroquine resistance in Plasmodium vivax, Antimicrob Agents Chemother, 48, 4075, 10.1128/AAC.48.11.4075-4083.2004 · DOI · Paper page
  21. NJ White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malar J, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
  22. HA Karunajeewa, 2008, A trial of combination antimalarial therapies in children from Papua New Guinea, N Engl J Med, 359, 2545, 10.1056/NEJMoa0804915 · DOI · Paper page
  23. JK Baird, 2003, Can primaquine therapy for vivax malaria be improved?, Trends Parasitol, 19, 115, 10.1016/S1471-4922(03)00005-9 · DOI · Paper page
  24. GK John, 2012, Primaquine radical cure of Plasmodium vivax: a critical review of the literature, Malar J, 11, 280, 10.1186/1475-2875-11-280 · DOI · Paper page
  25. KP Grietens, 2010, Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon, Am J Trop Med Hyg, 82, 1017, 10.4269/ajtmh.2010.09-0521 · DOI
  26. N Khantikul, 2009, Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand, J Health Popul Nutr, 27, 4, 10.3329/jhpn.v27i1.3313 · DOI · Paper page
  27. EA Pereira, 2011, Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region, Malar J, 10, 355, 10.1186/1475-2875-10-355 · DOI · Paper page
  28. R Takeuchi, 2010, Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border, Malar J, 9, 308, 10.1186/1475-2875-9-308 · DOI
  29. T Leslie, 2004, Compliance with 14-day primaquine therapy for radical cure of vivax malaria—a randomized placebo-controlled trial comparing unsupervised with supervised treatment, Trans R Soc Trop Med Hyg, 98, 168, 10.1016/S0035-9203(03)00041-5 · DOI · Paper page
  30. L von Seidlein, 2013, Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report, Malar J, 12, 112, 10.1186/1475-2875-12-112 · DOI · Paper page
  31. NM Douglas, 2013, Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study, PLoS Med, 10, e1001575, 10.1371/journal.pmed.1001575 · DOI · Paper page

Cited by

See all 82

Metadata

Authors
Abreha, T., Hwang, J., Thriemer, K., Tadesse, Y., Girma, S., Melaku, Z., Assef, A., Kassa, M., Chatfield, M. D., Landman, K. Z., Chenet, S. M., Lucchi, N. W., Udhayakumar, V., Zhou, Z., Shi, Y. P., Kachur, S. P., Jima, D., Kebede, A., Solomon, H., Mekasha, A., Alemayehu, B. H., Malone, J. L., Dissanayake, G., Teka, H., Auburn, S., von Seidlein, L., & Price, R. N.
Venue
PLOS Medicine
Published
2017-05-16
Volume
14
Issue
5
Pages
e1002299
ISSN
1549-1676
Cited by
82
References
1
Language
en
Funders
  • U.S. President's Malaria Initiative (Ethiopia Fiscal Year 2012 Budget)
  • Bill and Melinda Gates Foundation (OPP1054404)
  • Wellcome Trust (200909)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. https://app.cochat.ai/papers/10.1371/journal.pmed.1002299
The paper
Abreha, T., Hwang, J., Thriemer, K., Tadesse, Y., Girma, S., Melaku, Z., Assef, A., Kassa, M., Chatfield, M. D., Landman, K. Z., Chenet, S. M., Lucchi, N. W., Udhayakumar, V., Zhou, Z., Shi, Y. P., Kachur, S. P., Jima, D., Kebede, A., Solomon, H., . . . Price, R. N. (2017). Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002299

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.